Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 231

1.

Reply: Adult-onset distal spinal muscular atrophy: a new phenotype associated with KIF5A mutations.

Brenner D, Rosenbohm A, Yilmaz R, Müller K, Grehl T, Petri S, Meyer T, Grosskreutz J, Weydt P, Ruf W, Neuwirth C, Weber M, Pinto S, Claeys KG, Schrank B, Jordan B, Knehr A, Günther K, Hübers A, Zeller D, Kubisch C, Jablonka S, Sendtner M, Klopstock T, de Carvalho M, Sperfeld A, Borck G, Volk AE, Dorst J, Weis J, Otto M, Schuster J, Del Tredici K, Braak H, Danzer KM, Freischmidt A, Meitinger T, Ludolph AC, Andersen PM, Weishaupt JH; German ALS network MND-NET .

Brain. 2019 Oct 15. pii: awz306. doi: 10.1093/brain/awz306. [Epub ahead of print] No abstract available.

PMID:
31612906
2.

Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen.

Wurster CD, Steinacker P, Günther R, Koch JC, Lingor P, Uzelac Z, Witzel S, Wollinsky K, Winter B, Osmanovic A, Schreiber-Katz O, Al Shweiki R, Ludolph AC, Petri S, Hermann A, Otto M; MND-Net.

J Neurol. 2019 Sep 24. doi: 10.1007/s00415-019-09547-y. [Epub ahead of print]

PMID:
31552549
3.

Routine Cerebrospinal Fluid Cytology Reveals Unique Inclusions in Macrophages During Treatment With Nusinersen.

Gingele S, Hümmert MW, Alvermann S, Jendretzky KF, Bönig L, Brieskorn M, Schwenkenbecher P, Sühs KW, Müschen LH, Osmanovic A, Schreiber-Katz O, Stangel M, Petri S, Skripuletz T.

Front Neurol. 2019 Jul 11;10:735. doi: 10.3389/fneur.2019.00735. eCollection 2019.

4.

IncobotulinumtoxinA for hypersalivation in patients with amyotrophic lateral sclerosis: an open-label single-centre study.

Paracka L, Kollewe K, Klietz M, Petri S, Dressler D.

J Neural Transm (Vienna). 2019 Oct;126(10):1341-1345. doi: 10.1007/s00702-019-02044-6. Epub 2019 Jul 17.

PMID:
31317261
5.

Dyspnea in amyotrophic lateral sclerosis: The Dyspnea-ALS-Scale (DALS-15) essentially contributes to the diagnosis of respiratory impairment.

Vogt S, Schreiber S, Kollewe K, Körner S, Heinze HJ, Dengler R, Petri S, Vielhaber S.

Respir Med. 2019 Jul - Aug;154:116-121. doi: 10.1016/j.rmed.2019.06.014. Epub 2019 Jun 19.

PMID:
31234039
6.

Neurochemical markers in CSF of adolescent and adult SMA patients undergoing nusinersen treatment.

Wurster CD, Günther R, Steinacker P, Dreyhaupt J, Wollinsky K, Uzelac Z, Witzel S, Kocak T, Winter B, Koch JC, Lingor P, Petri S, Ludolph AC, Hermann A, Otto M.

Ther Adv Neurol Disord. 2019 May 10;12:1756286419846058. doi: 10.1177/1756286419846058. eCollection 2019.

7.

The Dyspnea-ALS-Scale (DALS-15) optimizes individual treatment in patients with amyotrophic lateral sclerosis (ALS) suffering from dyspnea.

Vogt S, Schreiber S, Heinze HJ, Dengler R, Petri S, Vielhaber S.

Health Qual Life Outcomes. 2019 Jun 3;17(1):95. doi: 10.1186/s12955-019-1167-0.

8.

Altered calcium dynamics and glutamate receptor properties in iPSC-derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations.

Bursch F, Kalmbach N, Naujock M, Staege S, Eggenschwiler R, Abo-Rady M, Japtok J, Guo W, Hensel N, Reinhardt P, Boeckers TM, Cantz T, Sterneckert J, Van Den Bosch L, Hermann A, Petri S, Wegner F.

Hum Mol Genet. 2019 Sep 1;28(17):2835-2850. doi: 10.1093/hmg/ddz107.

PMID:
31108504
9.

Influence of Environment and Lifestyle on Incidence and Progress of Amyotrophic Lateral Sclerosis in A German ALS Population.

Korner S, Kammeyer J, Zapf A, Kuzma-Kozakiewicz M, Piotrkiewicz M, Kuraszkiewicz B, Goszczynska H, Gromicho M, Grosskreutz J, Andersen PM, de Carvalho M, Petri S.

Aging Dis. 2019 Apr 1;10(2):205-216. doi: 10.14336/AD.2018.0327. eCollection 2019 Apr.

10.

Prognostic factors in ALS: a comparison between Germany and China.

Dorst J, Chen L, Rosenbohm A, Dreyhaupt J, Hübers A, Schuster J, Weishaupt JH, Kassubek J, Gess B, Meyer T, Weyen U, Hermann A, Winkler J, Grehl T, Hagenacker T, Lingor P, Koch JC, Sperfeld A, Petri S, Großkreutz J, Metelmann M, Wolf J, Winkler AS, Klopstock T, Boentert M, Johannesen S, Storch A, Schrank B, Zeller D, Liu XL, Tang L, Fan DS, Ludolph AC.

J Neurol. 2019 Jun;266(6):1516-1525. doi: 10.1007/s00415-019-09290-4. Epub 2019 Mar 28.

PMID:
30923935
11.

Isoform-selective as opposed to complete depletion of fibroblast growth factor 2 (FGF-2) has no major impact on survival and gene expression in SOD1G93A amyotrophic lateral sclerosis mice.

Kefalakes E, Sarikidi A, Bursch F, Ettcheto M, Schmuck M, Rumpel R, Grothe C, Petri S.

Eur J Neurosci. 2019 Sep;50(6):3028-3045. doi: 10.1111/ejn.14405. Epub 2019 Apr 8.

PMID:
30883949
12.

Analysis of the therapeutic potential of different administration routes and frequencies of human mesenchymal stromal cells in the SOD1G93A mouse model of amyotrophic lateral sclerosis.

Bursch F, Rath KJ, Sarikidi A, Böselt S, Kefalakes E, Osmanovic A, Thau-Habermann N, Klöß S, Köhl U, Petri S.

J Tissue Eng Regen Med. 2019 Apr;13(4):649-663. doi: 10.1002/term.2846. Epub 2019 Mar 20.

PMID:
30811816
13.

Toward in vivo determination of peripheral nervous system immune activity in amyotrophic lateral sclerosis.

Schreiber S, Schreiber F, Garz C, Debska-Vielhaber G, Assmann A, Perosa V, Petri S, Dengler R, Nestor P, Vielhaber S.

Muscle Nerve. 2019 May;59(5):567-576. doi: 10.1002/mus.26444. Epub 2019 Mar 8.

PMID:
30734322
14.

Expression of the axon-guidance protein receptor Neuropilin 1 is increased in the spinal cord and decreased in muscle of a mouse model of amyotrophic lateral sclerosis.

Körner S, Thau-Habermann N, Kefalakes E, Bursch F, Petri S.

Eur J Neurosci. 2019 Jun;49(11):1529-1543. doi: 10.1111/ejn.14326. Epub 2019 Jan 16.

PMID:
30589468
15.

Hybrid Sterility with Meiotic Metaphase Arrest in Intersubspecific Mouse Crosses.

Nishino R, Petri S, Handel MA, Kunieda T, Fujiwara Y.

J Hered. 2019 Mar 5;110(2):183-193. doi: 10.1093/jhered/esy060.

PMID:
30452700
16.

Projected changes in persistent extreme summer weather events: The role of quasi-resonant amplification.

Mann ME, Rahmstorf S, Kornhuber K, Steinman BA, Miller SK, Petri S, Coumou D.

Sci Adv. 2018 Oct 31;4(10):eaat3272. doi: 10.1126/sciadv.aat3272. eCollection 2018 Oct.

17.

Characterizing the multiple roles of FGF-2 in SOD1G93A ALS mice in vivo and in vitro.

Kefalakes E, Böselt S, Sarikidi A, Ettcheto M, Bursch F, Naujock M, Stanslowsky N, Schmuck M, Barenys M, Wegner F, Grothe C, Petri S.

J Cell Physiol. 2019 May;234(5):7395-7410. doi: 10.1002/jcp.27498. Epub 2018 Oct 28.

PMID:
30370540
18.

Significance of CSF NfL and tau in ALS.

Schreiber S, Spotorno N, Schreiber F, Acosta-Cabronero J, Kaufmann J, Machts J, Debska-Vielhaber G, Garz C, Bittner D, Hensiek N, Dengler R, Petri S, Nestor PJ, Vielhaber S.

J Neurol. 2018 Nov;265(11):2633-2645. doi: 10.1007/s00415-018-9043-0. Epub 2018 Sep 5.

PMID:
30187162
19.

Dyspnea in Amyotrophic Lateral Sclerosis: Rasch-Based Development and Validation of a Patient-Reported Outcome (DALS-15).

Vogt S, Petri S, Dengler R, Heinze HJ, Vielhaber S.

J Pain Symptom Manage. 2018 Nov;56(5):736-745.e2. doi: 10.1016/j.jpainsymman.2018.08.009. Epub 2018 Aug 24.

PMID:
30145215
20.

Alberta wildfire 2016: Apt contribution from anomalous planetary wave dynamics.

Petoukhov V, Petri S, Kornhuber K, Thonicke K, Coumou D, Schellnhuber HJ.

Sci Rep. 2018 Aug 17;8(1):12375. doi: 10.1038/s41598-018-30812-z.

21.

Global Hippocampal Volume Reductions and Local CA1 Shape Deformations in Amyotrophic Lateral Sclerosis.

Machts J, Vielhaber S, Kollewe K, Petri S, Kaufmann J, Schoenfeld MA.

Front Neurol. 2018 Jul 20;9:565. doi: 10.3389/fneur.2018.00565. eCollection 2018.

22.

Quantitative Susceptibility MRI to Detect Brain Iron in Amyotrophic Lateral Sclerosis.

Acosta-Cabronero J, Machts J, Schreiber S, Abdulla S, Kollewe K, Petri S, Spotorno N, Kaufmann J, Heinze HJ, Dengler R, Vielhaber S, Nestor PJ.

Radiology. 2018 Oct;289(1):195-203. doi: 10.1148/radiol.2018180112. Epub 2018 Jul 24.

23.

Dysregulation of a novel miR-1825/TBCB/TUBA4A pathway in sporadic and familial ALS.

Helferich AM, Brockmann SJ, Reinders J, Deshpande D, Holzmann K, Brenner D, Andersen PM, Petri S, Thal DR, Michaelis J, Otto M, Just S, Ludolph AC, Danzer KM, Freischmidt A, Weishaupt JH.

Cell Mol Life Sci. 2018 Dec;75(23):4301-4319. doi: 10.1007/s00018-018-2873-1. Epub 2018 Jul 20.

PMID:
30030593
24.

When Nursing Care and Clinical Trials Coincide: A Qualitative Study of the Views of Nordic Oncology and Hematology Nurses on Ethical Work Challenges.

Godskesen TE, Petri S, Eriksson S, Halkoaho A, Mangset M, Pirinen M, Nielsen ZE.

J Empir Res Hum Res Ethics. 2018 Dec;13(5):475-485. doi: 10.1177/1556264618783555. Epub 2018 Jul 12.

PMID:
29998780
25.

Association between attention-deficit/hyperactivity disorder (ADHD) and amyotrophic lateral sclerosis (ALS).

de Zwaan M, Ebel L, Petri S, Krauss JK, Dengler R.

J Neurol Sci. 2018 Aug 15;391:152. doi: 10.1016/j.jns.2018.06.018. Epub 2018 Jun 22. No abstract available.

PMID:
29961556
26.

Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.

Ludolph AC, Schuster J, Dorst J, Dupuis L, Dreyhaupt J, Weishaupt JH, Kassubek J, Weiland U, Petri S, Meyer T, Grosskreutz J, Schrank B, Boentert M, Emmer A, Hermann A, Zeller D, Prudlo J, Winkler AS, Grehl T, Heneka MT, Wollebæk Johannesen S, Göricke B; RAS-ALS Study Group.

Lancet Neurol. 2018 Aug;17(8):681-688. doi: 10.1016/S1474-4422(18)30176-5. Epub 2018 Jun 19.

PMID:
29934198
27.

Implementing Motor Unit Number Index (MUNIX) in a large clinical trial: Real world experience from 27 centres.

Neuwirth C, Braun N, Claeys KG, Bucelli R, Fournier C, Bromberg M, Petri S, Goedee S, Lenglet T, Leppanen R, Canosa A, Goodman I, Al-Lozi M, Ohkubo T, Hübers A, Atassi N, Abrahao A, Funke A, Appelfeller M, Tümmler A, Finegan E, Glass JD, Babu S, Ladha SS, Kwast-Rabben O, Juntas-Morales R, Coffey A, Chaudhry V, Vu T, Saephanh C, Newhard C, Zakrzewski M, Rosier E, Hamel N, Raheja D, Raaijman J, Ferguson T, Weber M.

Clin Neurophysiol. 2018 Aug;129(8):1756-1762. doi: 10.1016/j.clinph.2018.04.614. Epub 2018 May 3.

PMID:
29803404
28.

Differential involvement of forearm muscles in ALS does not relate to sonographic structural nerve alterations.

Schreiber S, Schreiber F, Debska-Vielhaber G, Garz C, Hensiek N, Machts J, Abdulla S, Dengler R, Petri S, Nestor PJ, Vielhaber S.

Clin Neurophysiol. 2018 Jul;129(7):1438-1443. doi: 10.1016/j.clinph.2018.04.610. Epub 2018 May 1.

PMID:
29751209
29.

Therapeutic decisions in ALS patients: cross-cultural differences and clinical implications.

Andersen PM, Kuzma-Kozakiewicz M, Keller J, Aho-Oezhan HEA, Ciecwierska K, Szejko N, Vázquez C, Böhm S, Badura-Lotter G, Meyer T, Petri S, Linse K, Hermann A, Semb O, Stenberg E, Nackberg S, Dorst J, Uttner I, Häggström AC, Ludolph AC, Lulé D.

J Neurol. 2018 Jul;265(7):1600-1606. doi: 10.1007/s00415-018-8861-4. Epub 2018 May 4.

PMID:
29728768
30.

Comprehensive analysis of the mutation spectrum in 301 German ALS families.

Müller K, Brenner D, Weydt P, Meyer T, Grehl T, Petri S, Grosskreutz J, Schuster J, Volk AE, Borck G, Kubisch C, Klopstock T, Zeller D, Jablonka S, Sendtner M, Klebe S, Knehr A, Günther K, Weis J, Claeys KG, Schrank B, Sperfeld AD, Hübers A, Otto M, Dorst J, Meitinger T, Strom TM, Andersen PM, Ludolph AC, Weishaupt JH; German ALS network MND-NET.

J Neurol Neurosurg Psychiatry. 2018 Aug;89(8):817-827. doi: 10.1136/jnnp-2017-317611. Epub 2018 Apr 12.

PMID:
29650794
31.

Age-dependent neurodegeneration and organelle transport deficiencies in mutant TDP43 patient-derived neurons are independent of TDP43 aggregation.

Kreiter N, Pal A, Lojewski X, Corcia P, Naujock M, Reinhardt P, Sterneckert J, Petri S, Wegner F, Storch A, Hermann A.

Neurobiol Dis. 2018 Jul;115:167-181. doi: 10.1016/j.nbd.2018.03.010. Epub 2018 Apr 6.

PMID:
29630989
32.

Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model.

Westeneng HJ, Debray TPA, Visser AE, van Eijk RPA, Rooney JPK, Calvo A, Martin S, McDermott CJ, Thompson AG, Pinto S, Kobeleva X, Rosenbohm A, Stubendorff B, Sommer H, Middelkoop BM, Dekker AM, van Vugt JJFA, van Rheenen W, Vajda A, Heverin M, Kazoka M, Hollinger H, Gromicho M, Körner S, Ringer TM, Rödiger A, Gunkel A, Shaw CE, Bredenoord AL, van Es MA, Corcia P, Couratier P, Weber M, Grosskreutz J, Ludolph AC, Petri S, de Carvalho M, Van Damme P, Talbot K, Turner MR, Shaw PJ, Al-Chalabi A, Chiò A, Hardiman O, Moons KGM, Veldink JH, van den Berg LH.

Lancet Neurol. 2018 May;17(5):423-433. doi: 10.1016/S1474-4422(18)30089-9. Epub 2018 Mar 26.

33.

The metabolic and endocrine characteristics in spinal and bulbar muscular atrophy.

Rosenbohm A, Hirsch S, Volk AE, Grehl T, Grosskreutz J, Hanisch F, Herrmann A, Kollewe K, Kress W, Meyer T, Petri S, Prudlo J, Wessig C, Müller HP, Dreyhaupt J, Weishaupt J, Kubisch C, Kassubek J, Weydt P, Ludolph AC.

J Neurol. 2018 May;265(5):1026-1036. doi: 10.1007/s00415-018-8790-2. Epub 2018 Feb 20.

PMID:
29464380
34.

Lack of an association between attention-deficit/hyperactivity disorder (ADHD) and amyotrophic lateral sclerosis (ALS).

Ebel L, Petri S, Krauss JK, Dengler R, de Zwaan M.

J Neurol Sci. 2018 Feb 15;385:7-11. doi: 10.1016/j.jns.2017.11.042. Epub 2017 Dec 1.

PMID:
29406917
35.

Provision of assistive technology devices among people with ALS in Germany: a platform-case management approach.

Funke A, Spittel S, Grehl T, Grosskreutz J, Kettemann D, Petri S, Weyen U, Weydt P, Dorst J, Ludolph AC, Baum P, Oberstadt M, Jordan B, Hermann A, Wolf J, Boentert M, Walter B, Gajewski N, Maier A, Münch C, Meyer T.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 Aug;19(5-6):342-350. doi: 10.1080/21678421.2018.1431786. Epub 2018 Jan 30.

PMID:
29382225
36.

Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation.

Naumann M, Pal A, Goswami A, Lojewski X, Japtok J, Vehlow A, Naujock M, Günther R, Jin M, Stanslowsky N, Reinhardt P, Sterneckert J, Frickenhaus M, Pan-Montojo F, Storkebaum E, Poser I, Freischmidt A, Weishaupt JH, Holzmann K, Troost D, Ludolph AC, Boeckers TM, Liebau S, Petri S, Cordes N, Hyman AA, Wegner F, Grill SW, Weis J, Storch A, Hermann A.

Nat Commun. 2018 Jan 23;9(1):335. doi: 10.1038/s41467-017-02299-1.

37.

Hot-spot KIF5A mutations cause familial ALS.

Brenner D, Yilmaz R, Müller K, Grehl T, Petri S, Meyer T, Grosskreutz J, Weydt P, Ruf W, Neuwirth C, Weber M, Pinto S, Claeys KG, Schrank B, Jordan B, Knehr A, Günther K, Hübers A, Zeller D, Kubisch C, Jablonka S, Sendtner M, Klopstock T, de Carvalho M, Sperfeld A, Borck G, Volk AE, Dorst J, Weis J, Otto M, Schuster J, Del Tredici K, Braak H, Danzer KM, Freischmidt A, Meitinger T, Strom TM, Ludolph AC, Andersen PM, Weishaupt JH; German ALS network MND-NET.

Brain. 2018 Mar 1;141(3):688-697. doi: 10.1093/brain/awx370.

38.

The TGF-β System As a Potential Pathogenic Player in Disease Modulation of Amyotrophic Lateral Sclerosis.

Peters S, Zitzelsperger E, Kuespert S, Iberl S, Heydn R, Johannesen S, Petri S, Aigner L, Thal DR, Hermann A, Weishaupt JH, Bruun TH, Bogdahn U.

Front Neurol. 2017 Dec 15;8:669. doi: 10.3389/fneur.2017.00669. eCollection 2017.

39.

Percutaneous endoscopic gastrostomy with and without jejunal extension in patients with amyotrophic lateral sclerosis.

Kirstein MM, Körner S, Schneider A, Manns MP, Petri S, Voigtländer T.

Eur J Gastroenterol Hepatol. 2018 Mar;30(3):257-262. doi: 10.1097/MEG.0000000000001054.

PMID:
29324589
40.

Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis.

Feneberg E, Oeckl P, Steinacker P, Verde F, Barro C, Van Damme P, Gray E, Grosskreutz J, Jardel C, Kuhle J, Koerner S, Lamari F, Amador MDM, Mayer B, Morelli C, Muckova P, Petri S, Poesen K, Raaphorst J, Salachas F, Silani V, Stubendorff B, Turner MR, Verbeek MM, Weishaupt JH, Weydt P, Ludolph AC, Otto M.

Neurology. 2018 Jan 2;90(1):e22-e30. doi: 10.1212/WNL.0000000000004761. Epub 2017 Dec 6.

PMID:
29212830
41.

Plekhg5-regulated autophagy of synaptic vesicles reveals a pathogenic mechanism in motoneuron disease.

Lüningschrör P, Binotti B, Dombert B, Heimann P, Perez-Lara A, Slotta C, Thau-Habermann N, R von Collenberg C, Karl F, Damme M, Horowitz A, Maystadt I, Füchtbauer A, Füchtbauer EM, Jablonka S, Blum R, Üçeyler N, Petri S, Kaltschmidt B, Jahn R, Kaltschmidt C, Sendtner M.

Nat Commun. 2017 Oct 30;8(1):678. doi: 10.1038/s41467-017-00689-z.

42.

HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients.

Guo W, Naujock M, Fumagalli L, Vandoorne T, Baatsen P, Boon R, Ordovás L, Patel A, Welters M, Vanwelden T, Geens N, Tricot T, Benoy V, Steyaert J, Lefebvre-Omar C, Boesmans W, Jarpe M, Sterneckert J, Wegner F, Petri S, Bohl D, Vanden Berghe P, Robberecht W, Van Damme P, Verfaillie C, Van Den Bosch L.

Nat Commun. 2017 Oct 11;8(1):861. doi: 10.1038/s41467-017-00911-y.

43.

July 2017 ENCALS statement on edaravone.

Al-Chalabi A, Andersen PM, Chandran S, Chio A, Corcia P, Couratier P, Danielsson O, de Carvalho M, Desnuelle C, Grehl T, Grosskreutz J, Holmøy T, Ingre C, Karlsborg M, Kleveland G, Koch JC, Koritnik B, KuzmaKozakiewicz M, Laaksovirta H, Ludolph A, McDermott C, Meyer T, Mitre Ropero B, Mora Pardina J, Nygren I, Petri S, Povedano Panades M, Salachas F, Shaw P, Silani V, Staaf G, Svenstrup K, Talbot K, Tysnes OB, Van Damme P, van der Kooi A, Weber M, Weydt P, Wolf J, Hardiman O, van den Berg LH.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Nov;18(7-8):471-474. doi: 10.1080/21678421.2017.1369125. Epub 2017 Oct 4. Review. No abstract available.

44.

International Survey of ALS Experts about Critical Questions for Assessing Patients with ALS.

De Carvalho M, Ryczkowski A, Andersen P, Gromicho M, Grosskreutz J, Kuźma-Kozakiewicz M, Petri S, Piotrkiewicz M, Miltenberger Miltenyi G.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Nov;18(7-8):505-510. doi: 10.1080/21678421.2017.1349150. Epub 2017 Jul 13.

PMID:
28705085
45.

Attenuated error-related potentials in amyotrophic lateral sclerosis with executive dysfunctions.

Seer C, Joop M, Lange F, Lange C, Dengler R, Petri S, Kopp B.

Clin Neurophysiol. 2017 Aug;128(8):1496-1503. doi: 10.1016/j.clinph.2017.05.007. Epub 2017 May 18.

PMID:
28628797
46.

Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 cases.

Schnitzler LJ, Schreckenbach T, Nadaj-Pakleza A, Stenzel W, Rushing EJ, Van Damme P, Ferbert A, Petri S, Hartmann C, Bornemann A, Meisel A, Petersen JA, Tousseyn T, Thal DR, Reimann J, De Jonghe P, Martin JJ, Van den Bergh PY, Schulz JB, Weis J, Claeys KG.

Orphanet J Rare Dis. 2017 May 11;12(1):86. doi: 10.1186/s13023-017-0640-2. Review.

47.

Peripheral nerve atrophy together with higher cerebrospinal fluid progranulin indicate axonal damage in amyotrophic lateral sclerosis.

Schreiber S, Debska-Vielhaber G, Abdulla S, Machts J, Schreiber F, Kropf S, KÖrtvelyessy P, KÖrner S, Kollewe K, Petri S, Dengler R, Kunz WS, Nestor PJ, Vielhaber S.

Muscle Nerve. 2018 Feb;57(2):273-278. doi: 10.1002/mus.25682. Epub 2017 May 22.

PMID:
28472860
48.

Deciphering pyritization-kerogenization gradient for fish soft-tissue preservation.

Osés GL, Petri S, Voltani CG, Prado GMEM, Galante D, Rizzutto MA, Rudnitzki ID, da Silva EP, Rodrigues F, Rangel EC, Sucerquia PA, Pacheco MLAF.

Sci Rep. 2017 May 3;7(1):1468. doi: 10.1038/s41598-017-01563-0.

49.

KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1.

Wolfson RL, Chantranupong L, Wyant GA, Gu X, Orozco JM, Shen K, Condon KJ, Petri S, Kedir J, Scaria SM, Abu-Remaileh M, Frankel WN, Sabatini DM.

Nature. 2017 Mar 16;543(7645):438-442. doi: 10.1038/nature21423. Epub 2017 Feb 15.

50.

Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial.

Meininger V, Genge A, van den Berg LH, Robberecht W, Ludolph A, Chio A, Kim SH, Leigh PN, Kiernan MC, Shefner JM, Desnuelle C, Morrison KE, Petri S, Boswell D, Temple J, Mohindra R, Davies M, Bullman J, Rees P, Lavrov A; NOG112264 Study Group.

Lancet Neurol. 2017 Mar;16(3):208-216. doi: 10.1016/S1474-4422(16)30399-4. Epub 2017 Jan 28.

Supplemental Content

Support Center